Medical Dermatology
Conference Coverage
Screen for comorbidities in pyoderma gangrenosum
PORTLAND, ORE. – A study of patients with pyoderma gangrenosum provides information about comorbidities to look out for in this population.
News from the FDA/CDC
Canagliflozin gets boxed warning for amputation
The risk of lower limb amputation associated with canagliflozin is now great enough to receive a boxed warning.
Conference Coverage
CC-220 shows efficacy, safety concerns in phase II SLE trial
The investigational agent CC-220 showed some efficacy but also important safety caveats in a 12-week, phase II trial.
Conference Coverage
Survey: Botulinum toxin achieves durable improvements in hyperhidrosis
SYDNEY, AUSTRALIA – Satisfaction with the effects of botulinum toxin therapy for axillary hyperhidrosis was high in a retrospective study of...